West Pharmaceutical Services (WST) Revenue — Quarter Ended Jun 30, 2024
Revenue for the quarter declined compared to both the prior quarter and the same period a year earlier. The sequential decrease continued a pattern of lower revenue from the previous quarter's level.
Key takeaway
Quarter ended Jun 30, 2024 · FY2024 Q2
Revenue for the quarter declined compared to both the prior quarter and the same period a year earlier. The sequential decrease continued a pattern of lower revenue from the previous quarter's level.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$702.1M
Revenue reported for this quarter.
Quarter-over-quarter
+1.0%
Change from the immediately preceding quarter.
Year-over-year
-6.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$2.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2023 | $747.4M | +8.8% |
| Dec 31, 2023 | $732M | +3.3% |
| Mar 31, 2024 | $695.4M | -3.0% |
| Jun 30, 2024 | $702.1M | -6.9% |
Revenue performance
Reported net sales were lower than in the preceding quarter, marking a continuation of the downward trajectory observed in the prior period.
Quarterly comparison
Compared with the same quarter last year, net sales were also lower. The sequential comparison shows a modest improvement over the prior quarter's decline rate.
What to watch
Monitor whether the revenue trend stabilizes given the sequential decline after two quarters of deceleration.